BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright ©The Author(s) 2026.
World J Cardiol. Feb 26, 2026; 18(2): 111861
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.111861
Table 1 Case study general data, mean ± SD

Case study (n = 3)
Control group (n = 10)
Age (years)46.352.3
LVEF (%)52.353.5
V2S/V3R ratio1.611.68
Beta blockers 3/38/10
Flecainide3/39/10
Amiodarone0/31/10
Total RF delivery time (minutes)5.0 ± 14.3 ± 1.8
Single lesion impedance drop (ohms)11.9 ± 1.7 13.5 ± 2.1
PVCs recurrence (6 months follow-up)0/31/10